BOUNDLESS BIO, INC. (BOLD) Operating cash flow 2023–2025
BOUNDLESS BIO, INC. (BOLD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$46.7MFY2025 · since FY2023: -$46.9M → -$46.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.7M | +23.3% |
| FY2024 | -$60.8M | -29.8% |
| FY2023 | -$46.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLD financial trends
BOLD RevenueBOLD Net incomeBOLD Net marginBOLD Gross profitBOLD Gross marginBOLD Operating incomeBOLD Operating marginBOLD Free cash flowBOLD Capital expendituresBOLD Return on equityBOLD Stock buybacksBOLD Dividends paidBOLD Total assetsBOLD Total liabilitiesBOLD Shareholders’ equityBOLD overview →